Korean J Stroke.
2012 Dec;14(3):95-105.
Focused Update of Korean Clinical Practice Guidelines for the Thrombolysis in Acute Stroke Management
- Affiliations
-
- 1Department of Neurology, Korea University College of Medicine, Seoul, Korea.
- 2Department of Neurology, Seoul National University College of Medicine, Seoul, Korea.
- 3Department of Neurology, Dong-A University College of Medicine, Busan, Korea.
- 4Department of Neurology, Inha University College of Medicine, Incheon, Korea. jhrha@inha.ac.kr
- 5Department of Neurology, The Catholic University College of Medicine, Seoul, Korea.
- 6Department of Neurology, Inje University College of Medicine, Busan, Korea.
- 7Department of Neurology, Hallym University College of Medicine, Chuncheon, Korea.
- 8Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
- 9Department of Neurology, Ulsan University College of Medicine, Seoul, Korea.
- 10Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.
Abstract
- Since the release of first Korean Clinical Practice Guideline of Stroke in 2009, many important new evidences have emerged in the field of thrombolytic therapy. Among the recent developments are the extended therapeutic time window of intravenous (IV) tissue plasminogen activator (tPA) up to 4.5 hours after onset, and the efforts for the wider application of IV thrombolysis to patients with minor stroke and elderly patients over 80 years old. Debates about the optimal dose of IV tPA according to the ethnic population is still ongoing. Further evidences for the efficacy of intra-arterial thrombolysis have also accumulated, including the application of various novel mechanical devices with promising results. Thus update of guideline became necessary and we revise the acute stroke management guideline, focusing on the thrombolytic therapy.